Download presentation
Presentation is loading. Please wait.
Published byLaurence Sparks Modified over 9 years ago
1
PET in Colorectal Cancer
2
Indications for FDG PET Rising marker, (-) CT/MRI Nonspecific findings on CT/MRI, recurrence or post treatment changes? Known metastases; evaluate extent or disease or identify other sites of recurrence Evaluate response to chemotherapy
3
LV 12/09/93 04/23/9608/22/96 PET-FDG SCAN IN RECTAL CA 191642
4
Coronal MSKCCAL361200
5
Case 1
6
Comparison of PET and CT N=40 pts. (93 biopsies) W CT =0.73+/-.06* W PET =0.97/-.02* *P<.001
7
Biopsy Correlated Finding
9
Diagnostic Imaging in Oncology Detection Differential Diagnosis Tumor biology relevant to therapy Staging Recurrence Response
10
PET in Colorectal Cancer PET accuracy between 88 - 92% > CT (75%) Among pt.s with suspected recurrence, SUV > 3.5 has a 90% probability of tumor, and a 10% prob of being a benign lesion Most common reasons for missing lesions is size (< 1 cm in diameter), location (peritoneum), and artifact (lesion near high count area) PET >> CT for Rx response in rectal Ca
Similar presentations
© 2025 SlidePlayer.com. Inc.
All rights reserved.